You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The partners are aiming to develop mass spectrometry-based data analysis software for use in lipidomics research.
Premier Biosoft and Bruker have entered a reselling agreement for the lipid and metabolite software packages.
NEW YORK (GenomeWeb) – Certain Agilent Technologies mass spectrometers and liquid chromatography instruments now support Premier Biosoft's SimGlycan glycomics software as part of a deal announced today.
Roche this week launched new software updates, including advanced high-resolution melting analysis and qualitative detection modules, for the LightCycler 96 system.
Premier Biosoft said this week that it has bought ProteoIQ, a proteomic data-analysis software suite, from Australian bioseparations company NuSep for an undisclosed sum.
NEW YORK (GenomeWeb News) – Premier Biosoft said on Monday it has completed the acquisition of NuSep's software business ProteoIQ for an undisclosed amount.
NEW YORK (GenomeWeb News) – Agilent Technologies and Premier Biosoft today said they will support the combination of each other's technologies to advance lipidomics research.
Agilent this week announced a collaboration with South Korea's Gachon University of Medicine and Science for the discovery of protein and glycoprotein biomarkers in diabetes and cancer.
NEW YORK (GenomeWeb News) – Premier Biosoft today announced a co-marketing and reselling deal with AB Sciex for lipidomic research software.
NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said it has signed an agreement to co-market Premier Biosoft's SimGlycan software for analyzing glycan-based data.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.